HEADER PROTEIN BINDING/ACTIVATOR 03-DEC-16 5U3V TITLE HUMAN PPARDELTA LIGAND-BINDING DOMAIN IN COMPLEXED WITH SPECIFIC TITLE 2 AGONIST 6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-DELTA,NUCI,NUCLEAR HORMONE RECEPTOR 1,NUC1,NUCLEAR COMPND 5 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2,PEROXISOME PROLIFERATOR- COMPND 6 ACTIVATED RECEPTOR BETA,PPAR-BETA; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: LIGAND-BINDING DOMAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A(+) KEYWDS PPARDELTA, LIGAND-BINDING DOMAIN, AGONIST, PROTEIN BINDING-ACTIVATOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.-C.WU,T.J.BAIGA,M.DOWNES,J.J.LA CLAIR,A.R.ATKINS,S.B.RICHARD, AUTHOR 2 T.A.STOCKLEY-NOEL,M.E.BOWMAN,R.M.EVANS,J.P.NOEL REVDAT 5 04-OCT-23 5U3V 1 HETSYN REVDAT 4 29-JUL-20 5U3V 1 COMPND REMARK HETNAM SITE REVDAT 4 2 1 ATOM REVDAT 3 05-APR-17 5U3V 1 JRNL REVDAT 2 29-MAR-17 5U3V 1 JRNL REVDAT 1 22-MAR-17 5U3V 0 JRNL AUTH C.C.WU,T.J.BAIGA,M.DOWNES,J.J.LA CLAIR,A.R.ATKINS, JRNL AUTH 2 S.B.RICHARD,W.FAN,T.A.STOCKLEY-NOEL,M.E.BOWMAN,J.P.NOEL, JRNL AUTH 3 R.M.EVANS JRNL TITL STRUCTURAL BASIS FOR SPECIFIC LIGATION OF THE PEROXISOME JRNL TITL 2 PROLIFERATOR-ACTIVATED RECEPTOR DELTA. JRNL REF PROC. NATL. ACAD. SCI. V. 114 E2563 2017 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 28320959 JRNL DOI 10.1073/PNAS.1621513114 REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 59587 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.190 REMARK 3 FREE R VALUE TEST SET COUNT : 1900 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.7224 - 4.4336 0.99 4309 129 0.1764 0.2162 REMARK 3 2 4.4336 - 3.5194 0.99 4214 173 0.1671 0.2156 REMARK 3 3 3.5194 - 3.0746 1.00 4253 116 0.2020 0.2347 REMARK 3 4 3.0746 - 2.7936 1.00 4242 152 0.2129 0.2785 REMARK 3 5 2.7936 - 2.5933 1.00 4223 136 0.2022 0.2359 REMARK 3 6 2.5933 - 2.4405 1.00 4245 140 0.1989 0.2583 REMARK 3 7 2.4405 - 2.3182 1.00 4193 139 0.1916 0.2499 REMARK 3 8 2.3182 - 2.2173 1.00 4216 135 0.1936 0.2079 REMARK 3 9 2.2173 - 2.1320 1.00 4254 147 0.2148 0.2725 REMARK 3 10 2.1320 - 2.0584 1.00 4190 137 0.2179 0.2751 REMARK 3 11 2.0584 - 1.9940 1.00 4234 130 0.2319 0.2911 REMARK 3 12 1.9940 - 1.9370 0.99 4154 144 0.2736 0.3163 REMARK 3 13 1.9370 - 1.8860 0.94 3945 127 0.3133 0.3298 REMARK 3 14 1.8860 - 1.8400 0.70 3015 95 0.3362 0.3329 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4859 REMARK 3 ANGLE : 1.087 6549 REMARK 3 CHIRALITY : 0.055 737 REMARK 3 PLANARITY : 0.007 817 REMARK 3 DIHEDRAL : 11.598 2933 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN 'A' AND RESID 173 THROUGH 441) REMARK 3 ORIGIN FOR THE GROUP (A): 25.8160 -1.2005 221.3205 REMARK 3 T TENSOR REMARK 3 T11: 0.2098 T22: 0.1887 REMARK 3 T33: 0.1630 T12: 0.0162 REMARK 3 T13: 0.0049 T23: -0.0082 REMARK 3 L TENSOR REMARK 3 L11: 1.0531 L22: 1.3011 REMARK 3 L33: 3.8005 L12: -0.2267 REMARK 3 L13: -0.3135 L23: 0.6161 REMARK 3 S TENSOR REMARK 3 S11: -0.0118 S12: -0.0369 S13: 0.0620 REMARK 3 S21: 0.0762 S22: 0.0928 S23: -0.0140 REMARK 3 S31: -0.1943 S32: -0.2940 S33: -0.0699 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN 'B' AND RESID 170 THROUGH 440) REMARK 3 ORIGIN FOR THE GROUP (A): 27.9078 -38.8038 207.5772 REMARK 3 T TENSOR REMARK 3 T11: 0.1093 T22: 0.1356 REMARK 3 T33: 0.1535 T12: -0.0099 REMARK 3 T13: -0.0217 T23: -0.0308 REMARK 3 L TENSOR REMARK 3 L11: 1.2868 L22: 1.5323 REMARK 3 L33: 2.4982 L12: 0.0290 REMARK 3 L13: -0.5337 L23: 0.5066 REMARK 3 S TENSOR REMARK 3 S11: -0.0125 S12: 0.0947 S13: -0.0610 REMARK 3 S21: 0.0796 S22: -0.0108 S23: 0.0338 REMARK 3 S31: 0.0345 S32: -0.1642 S33: 0.0083 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5U3V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225265. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 - 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59681 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.840 REMARK 200 RESOLUTION RANGE LOW (A) : 95.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1GWZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BIS-TRIS PROPANE, POTASSIUM CHLORIDE, REMARK 280 PEG 8000, 1,2-PROPANDIOL, EDTA, DTT, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.52500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 VAL A 172 REMARK 465 GLY A 203 REMARK 465 LYS A 204 REMARK 465 ALA A 205 REMARK 465 SER A 206 REMARK 465 HIS A 207 REMARK 465 THR A 208 REMARK 465 SER B 206 REMARK 465 HIS B 207 REMARK 465 THR B 208 REMARK 465 TYR B 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH22 ARG A 198 O VAL A 298 1.47 REMARK 500 HZ3 LYS A 265 O HOH A 603 1.58 REMARK 500 O HOH B 631 O HOH B 742 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 699 O HOH B 743 28510 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 198 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG B 198 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 227 -40.65 -144.15 REMARK 500 GLN A 230 -74.99 68.79 REMARK 500 LEU A 231 145.99 -38.33 REMARK 500 ASN A 233 -75.47 16.40 REMARK 500 LYS A 239 -48.42 -133.23 REMARK 500 ASN A 366 74.43 -104.84 REMARK 500 GLU A 424 68.11 -110.47 REMARK 500 ASP A 439 43.92 -109.47 REMARK 500 LYS B 204 46.98 -86.87 REMARK 500 VAL B 227 -60.39 -122.89 REMARK 500 GLN B 230 -52.59 69.26 REMARK 500 LYS B 239 -53.49 -120.40 REMARK 500 ASN B 366 77.15 -112.75 REMARK 500 GLU B 424 70.41 -117.36 REMARK 500 ASP B 439 65.93 39.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN A 230 LEU A 231 -136.71 REMARK 500 VAL A 232 ASN A 233 146.74 REMARK 500 GLN B 230 LEU B 231 -142.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5U3Q RELATED DB: PDB REMARK 900 RELATED ID: 5U3R RELATED DB: PDB REMARK 900 RELATED ID: 5U3S RELATED DB: PDB REMARK 900 RELATED ID: 5U3T RELATED DB: PDB REMARK 900 RELATED ID: 5U3U RELATED DB: PDB REMARK 900 RELATED ID: 5U3W RELATED DB: PDB REMARK 900 RELATED ID: 5U3X RELATED DB: PDB REMARK 900 RELATED ID: 5U3Y RELATED DB: PDB REMARK 900 RELATED ID: 5U3Z RELATED DB: PDB REMARK 900 RELATED ID: 5U40 RELATED DB: PDB REMARK 900 RELATED ID: 5U41 RELATED DB: PDB REMARK 900 RELATED ID: 5U42 RELATED DB: PDB REMARK 900 RELATED ID: 5U44 RELATED DB: PDB REMARK 900 RELATED ID: 5U45 RELATED DB: PDB REMARK 900 RELATED ID: 5U46 RELATED DB: PDB DBREF 5U3V A 170 441 UNP Q03181 PPARD_HUMAN 72 343 DBREF 5U3V B 170 441 UNP Q03181 PPARD_HUMAN 72 343 SEQRES 1 A 272 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 2 A 272 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 3 A 272 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 4 A 272 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 5 A 272 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 6 A 272 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 7 A 272 ARG CYS GLN CME THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 8 A 272 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 9 A 272 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 A 272 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 11 A 272 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 12 A 272 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 13 A 272 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 A 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 15 A 272 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 16 A 272 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 17 A 272 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 18 A 272 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 19 A 272 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 20 A 272 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 21 A 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 272 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 2 B 272 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 3 B 272 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 4 B 272 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 5 B 272 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 6 B 272 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 7 B 272 ARG CYS GLN CME THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 8 B 272 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 9 B 272 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 B 272 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 11 B 272 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 12 B 272 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 13 B 272 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 B 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 15 B 272 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 16 B 272 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 17 B 272 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 18 B 272 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 19 B 272 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 20 B 272 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 21 B 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR MODRES 5U3V CME A 251 CYS MODIFIED RESIDUE MODRES 5U3V CME B 251 CYS MODIFIED RESIDUE HET CME A 251 18 HET CME B 251 18 HET B7G A 501 45 HET 7TY A 502 67 HET PEG A 503 17 HET PEG A 504 17 HET PGO A 505 13 HET PEG A 506 17 HET B7G A 507 45 HET PGO B 501 26 HET 7TY B 502 67 HET PEG B 503 34 HET PGO B 504 13 HET PEG B 505 17 HET PEG B 506 17 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM B7G HEPTYL BETA-D-GLUCOPYRANOSIDE HETNAM 7TY 6-[2-({CYCLOPENTYL[4-(FURAN-3-YL)BENZENE-1- HETNAM 2 7TY CARBONYL]AMINO}METHYL)PHENOXY]HEXANOIC ACID HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PGO S-1,2-PROPANEDIOL HETSYN B7G HEPTYL-BETA-D-GLUCOPYRANOSIDE; HEPTYL BETA-D-GLUCOSIDE; HETSYN 2 B7G HEPTYL D-GLUCOSIDE; HEPTYL GLUCOSIDE FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 3 B7G 2(C13 H26 O6) FORMUL 4 7TY 2(C29 H33 N O5) FORMUL 5 PEG 6(C4 H10 O3) FORMUL 7 PGO 3(C3 H8 O2) FORMUL 16 HOH *275(H2 O) HELIX 1 AA1 ASP A 174 PHE A 190 1 17 HELIX 2 AA2 THR A 193 THR A 202 1 10 HELIX 3 AA3 ASP A 215 LEU A 226 1 12 HELIX 4 AA4 LEU A 231 LEU A 235 5 5 HELIX 5 AA5 GLU A 240 SER A 266 1 27 HELIX 6 AA6 ILE A 267 SER A 272 1 6 HELIX 7 AA7 PHE A 274 ALA A 295 1 22 HELIX 8 AA8 ARG A 314 SER A 319 1 6 HELIX 9 AA9 PRO A 323 ALA A 340 1 18 HELIX 10 AB1 ASP A 344 LEU A 357 1 14 HELIX 11 AB2 ASN A 366 HIS A 389 1 24 HELIX 12 AB3 TYR A 394 GLU A 424 1 31 HELIX 13 AB4 HIS A 430 LYS A 438 1 9 HELIX 14 AB5 GLN B 171 PHE B 190 1 20 HELIX 15 AB6 THR B 193 GLY B 203 1 11 HELIX 16 AB7 ASP B 215 LYS B 224 1 10 HELIX 17 AB8 GLU B 240 SER B 266 1 27 HELIX 18 AB9 ILE B 267 SER B 272 1 6 HELIX 19 AC1 PHE B 274 ALA B 295 1 22 HELIX 20 AC2 ARG B 314 LEU B 320 1 7 HELIX 21 AC3 PRO B 323 ALA B 340 1 18 HELIX 22 AC4 ASP B 344 LEU B 357 1 14 HELIX 23 AC5 ASN B 366 HIS B 389 1 24 HELIX 24 AC6 TYR B 394 GLU B 424 1 31 HELIX 25 AC7 HIS B 430 LYS B 438 1 9 SHEET 1 AA1 4 PHE A 211 ILE A 213 0 SHEET 2 AA1 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA1 4 GLY A 302 VAL A 305 -1 N LEU A 303 O VAL A 312 SHEET 4 AA1 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302 SHEET 1 AA2 4 PHE B 211 ILE B 213 0 SHEET 2 AA2 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 AA2 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312 SHEET 4 AA2 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 LINK C GLN A 250 N CME A 251 1555 1555 1.34 LINK C CME A 251 N THR A 252 1555 1555 1.32 LINK C GLN B 250 N CME B 251 1555 1555 1.34 LINK C CME B 251 N THR B 252 1555 1555 1.32 CISPEP 1 LYS A 322 PRO A 323 0 2.40 CISPEP 2 LYS B 322 PRO B 323 0 5.58 CRYST1 39.610 95.050 96.320 90.00 97.87 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025246 0.000000 0.003490 0.00000 SCALE2 0.000000 0.010521 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010481 0.00000